+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Viral Vector"

Ebola Drugs and Vaccines - Global Strategic Business Report - Product Thumbnail Image

Ebola Drugs and Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 485 Pages
  • Global
From
Vaccine Technologies - Global Strategic Business Report - Product Thumbnail Image

Vaccine Technologies - Global Strategic Business Report

  • Report
  • October 2025
  • 573 Pages
  • Global
From
Biopharma Buffer - Global Strategic Business Report - Product Thumbnail Image

Biopharma Buffer - Global Strategic Business Report

  • Report
  • October 2025
  • 578 Pages
  • Global
From
Adenovirus Vaccines - Global Strategic Business Report - Product Thumbnail Image

Adenovirus Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 279 Pages
  • Global
From
Respiratory Disease Vaccines - Global Strategic Business Report - Product Thumbnail Image

Respiratory Disease Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 475 Pages
  • Global
From
DNA Vaccines - Global Strategic Business Report - Product Thumbnail Image

DNA Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 171 Pages
  • Global
From
From
Combination Vaccines - Global Strategic Business Report - Product Thumbnail Image

Combination Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 373 Pages
  • Global
From
Live Attenuated Vaccines - Global Strategic Business Report - Product Thumbnail Image

Live Attenuated Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 563 Pages
  • Global
From
Biopharmaceutical CMO and CRO - Global Strategic Business Report - Product Thumbnail Image

Biopharmaceutical CMO and CRO - Global Strategic Business Report

  • Report
  • October 2025
  • 372 Pages
  • Global
From
From
From
Preventable Vaccines - Global Strategic Business Report - Product Thumbnail Image

Preventable Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 391 Pages
  • Global
From
Therapeutic Vaccines - Global Strategic Business Report - Product Thumbnail Image

Therapeutic Vaccines - Global Strategic Business Report

  • Report
  • October 2025
  • 182 Pages
  • Global
From
Vaccine Delivery Devices - Global Strategic Business Report - Product Thumbnail Image

Vaccine Delivery Devices - Global Strategic Business Report

  • Report
  • October 2025
  • 282 Pages
  • Global
From
From
Vaccine Storage and Packaging Market Report 2025 - Product Thumbnail Image

Vaccine Storage and Packaging Market Report 2025

  • Report
  • October 2025
  • 250 Pages
  • Global
From
Adult Vaccines Market Report 2025 - Product Thumbnail Image

Adult Vaccines Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Peptide Therapeutics Market Report 2025 - Product Thumbnail Image

Peptide Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Biologics CDMO Market Report 2025 - Product Thumbnail Image

Biologics CDMO Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Loading Indicator

The Viral Vector market is a subset of the biotechnology industry that focuses on the development and production of viral vectors for gene therapy. Viral vectors are modified viruses that are used to deliver genetic material into cells, allowing for the expression of a desired gene. This technology has been used to treat a variety of diseases, including cancer, genetic disorders, and infectious diseases. Viral vectors are produced through a variety of methods, including recombinant DNA technology, synthetic biology, and cell-based systems. The production of viral vectors requires specialized equipment and expertise, making it a highly specialized field. The Viral Vector market is highly competitive, with a number of companies offering products and services. Some of the major players in the market include Novartis, Merck, Pfizer, AstraZeneca, and Sanofi. Additionally, there are a number of smaller companies that specialize in the production of viral vectors, such as Viralgen, Oxford BioMedica, and Vigene Biosciences. Show Less Read more